Partnerships
Built for collaboration
CMIT's vertically integrated operation accelerates the radiopharmaceutical value chain under one roof, from discovery to patient care.
Our partners leverage our development infrastructure, regulatory experience, and clinical capabilities to safely and rapidly advance novel theranostics.
Featured Partnership
Starget × CMIT
A strategic collaboration combining Starget’s AI-driven radioligand discovery with CMIT’s integrated translational, manufacturing, and clinical capabilities.
Ochsner LSU Partnership
CMIT serves as an imaging partner for Ochsner LSU’s health centers in North Louisiana. The partnership expands patient access to state-of-the-art diagnostic and therapeutic imaging and cutting edge clinical trials
Cook Children's Medical Center
CMIT provides specialized radiopharmaceuticals to detect hyperinsulinism in infants at Cook Children’s Medical Center in Fort Worth, Texas. The Cook Children’s Hyperinsulinism Center is one of six Centers of Excellence in the world designated by Congenital Hyperinsulinism International.
LSU Health Shreveport Partnership
CMIT is a co-investigator on a pilot project using C-11 radiopharmaceutical to assist in a stimulant use disorder study, assessing the persistent behavioral and neurochemical effects of exposure to various classes of stimulants. The research aims to identify novel drug targets to prevent devastating adverse events associated with stimulant overdose.
How BRF and CMIT work together
BRF connects its operating divisions and strategic partners to move innovation from discovery into real-world scientific and economic impact.
A division of BRF
